| Immunotherapy in melanoma: recent advances and future directions A Knight, L Karapetyan, JM Kirkwood Cancers 15 (4), 1106, 2023 | 66 | 2023 |
| Access to palliative care for cancer patients living in a northern and rural environment in Ontario, Canada: the effects of geographic region and rurality on end-of-life care … MSC Conlon, JM Caswell, SA Santi, B Ballantyne, ML Meigs, A Knight, ... Clinical Medicine Insights: Oncology 13, 1179554919829500, 2019 | 31 | 2019 |
| Impact of comprehensive hospice palliative care on end-of-life care: a propensity-score–matched retrospective observational study MSC Conlon, JM Caswell, A Knight, B Ballantyne, SA Santi, ML Meigs, ... Canadian Medical Association Open Access Journal 7 (2), E197-E202, 2019 | 9 | 2019 |
| Access to oncology consultation in a cancer cohort in northeastern Ontario M Conlon, M Hartman, B Ballantyne, N Aubin, M Meigs, A Knight Current Oncology 22 (2), 69-75, 2015 | 8 | 2015 |
| Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes L Karapetyan, HM AbuShukair, A Li, A Knight, AN Al Bzour, IP MacFawn, ... Frontiers in Immunology 14, 1171978, 2023 | 3 | 2023 |
| Multiple primary melanoma in association with other personal and familial cancers X Yang, L Karapetyan, Z Huang, AD Knight, S Rajendran, C Sander, ... Cancer Medicine 12 (3), 2474-2483, 2023 | 3 | 2023 |
| Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma L Karapetyan, W Gooding, A Li, X Yang, A Knight, HM Abushukair, ... Cancers 14 (20), 4973, 2022 | 3 | 2022 |
| Immunotherapy in Melanoma: Recent Advances and Future Directions. Cancers 2023, 15, 1106 A Knight, L Karapetyan, JM Kirkwood | 2 | 2023 |
| Serum multiplex analysis of checkpoint proteins in association with immune-related adverse events in patients with melanoma receiving adjuvant anti-PD-1 therapy. AD Knight, S Bruno, CJ Layding, H Wang, C Sander, WJ Storkus, ... Journal of Clinical Oncology 42 (16_suppl), 9588-9588, 2024 | | 2024 |
| Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma. S Bruno, AD Knight, H Wang, C Sander, L Karapetyan, JM Kirkwood Journal of Clinical Oncology 42 (16_suppl), 9589-9589, 2024 | | 2024 |
| Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy AD Knight, JJ Luke Current Oncology Reports, 1-14, 2024 | | 2024 |
| 62 Pathological, transcriptomic and prognostic assessment of lymphoid aggregates in patients with primary and metastatic melanoma L Karapetyan, A Li, DV De Stefano, A Al-Bzour, H Abushukair, A Knight, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum: Outcomes for patients with melanoma. L Karapetyan, HM Abushukair, A Li, AD Knight, AN Al-Bzour, I Macfawn, ... Journal of Clinical Oncology 41 (16_suppl), 9565-9565, 2023 | | 2023 |
| Prognostic significance of immune-related adverse events and immunosuppression in patients with melanoma receiving adjuvant anti-PD-1 therapy. AD Knight, L Karapetyan, S Bruno, HM Abushukair, N Bo, H Wang, ... Journal of Clinical Oncology 41 (16_suppl), 9580-9580, 2023 | | 2023 |
| The prognostic significance of a 12-chemokine tertiary lymphoid structure (TLS) gene signature in uveal melanoma (UM) HM Abushukair, A Al-Bzour, A Knight, WJ Storkus, JM Kirkwood, ... Cancer Research 83 (7_Supplement), 4655-4655, 2023 | | 2023 |
| 1267 The effect of immunosuppression during anti-PD-1 treatment for stage III melanoma A Knight, J Kirkwood, L Karapetyan, X Yang, S Rajendran, N Bo, H Wang, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Sentinel lymph node gene expression signature predicts survival outcome in cutaneous melanoma L Karapetyan, W Gooding, X Yang, A Knight, A Li, C Sander, M Panelli, ... Cancer Research 82 (12_Supplement), 5169-5169, 2022 | | 2022 |
| Evaluation of the Melanoma Institute Australia nomogram in predicting sentinel lymph node positivity in patients with cutaneous melanoma X Yang, L Karapetyan, AD Knight, C Sander, WE Gooding, JM Kirkwood Cancer Research 82 (12_Supplement), 5877-5877, 2022 | | 2022 |
| Poorer survival outcomes in patients with multiple versus single primary melanoma L Karapetyan, X Yang, AD Knight, Z Huang, H Wang, CA Sander, ... Cancer 128 (11), 2098-2106, 2022 | | 2022 |
| Access to medical or radiation oncology consultation in patients who died from cancer in the Sudbury-Manitoulin District of Northeastern Ontario, Canada M Conlon, M Hartman, B Ballantyne, M Bewick, M Meigs, N Aubin, ... Cancer Research 74 (19_Supplement), 4141-4141, 2014 | | 2014 |
